Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Osteomalacia is a metabolic bone disorder caused by defective bone mineralization, most often from vitamin D, calcium, or phosphate deficiency, so it cannot be caught from or passed to another person through contact. While the condition itself is not contagious, certain inherited forms such as X-linked hypophosphatemia or vitamin D-dependent rickets can be transmitted genetically from parent to child, which is why family history matters. Other cases stem from kidney disease, malabsorption disorders, liver problems, or long-term use of specific medications rather than genetics at all. Distinguishing an inherited cause from an acquired one changes how the condition is monitored, treated, and discussed with relatives, and there are several important factors to consider. See below to understand more.
If you have been noticing bone pain, muscle weakness, difficulty walking, or unexplained fractures, guessing at the cause can delay treatment that is often straightforward once the source is identified. A free, instant, online symptom check can help you organize what you are experiencing, understand which explanations fit your pattern of symptoms, and see which type of clinician or lab testing may be the right next step. It takes only a few minutes, requires no signup, and gives you clearer language to bring to your doctor so nothing important gets overlooked.
Last reviewed for medical accuracy: 08/18/2026
Osteomalacia is a condition characterized by softening of the bones in adults, most commonly due to inadequate vitamin D, calcium or phosphate. You may wonder, “Is osteomalacia hereditary or contagious?” The short answer is that osteomalacia is a metabolic bone disorder, not an infection—it does not spread from person to person. While rare genetic predispositions exist, most cases are acquired through nutritional deficiencies or other metabolic issues.
Osteomalacia literally means “soft bone.” In children, a similar condition called rickets affects growing bones, but osteomalacia in adults develops when new bone matrix fails to mineralize properly. Key features include:
Because the problem lies in the metabolism of essential minerals—chiefly vitamin D, calcium, and phosphate—osteomalacia is classified as a metabolic bone disease rather than a genetic or infectious one.
Metabolic disorders arise when the body cannot process or regulate nutrients appropriately. In osteomalacia, these processes go awry:
Vitamin D Deficiency
Calcium Shortage
Phosphate Imbalance
Disorders of Vitamin D Activation
Because the root cause is metabolic, osteomalacia does not involve bacteria, viruses, or other pathogens. It cannot be caught like the flu or a cold.
Absolutely not. Osteomalacia:
Your risk stems from your own metabolic health, diet, sun exposure, and medical conditions—not from being near someone with the disease.
Most cases of osteomalacia are acquired, meaning they develop over time due to lifestyle or health factors. However, a small number of rare genetic disorders can lead to bone softening:
Even in these inherited disorders, the mechanism remains metabolic: the genes involved control processes like phosphate reabsorption or vitamin D metabolism. In other words, while some genetic factors can predispose a person to osteomalacia-like changes, osteomalacia itself is not a straightforward inherited disease like cystic fibrosis or sickle cell anemia.
Key takeaway:
Whether genetically influenced or acquired, several factors increase the risk of osteomalacia:
Early osteomalacia can be subtle. Watch for:
If you notice these symptoms, a free, online symptom check, using the doctor approved Ubie Symptom Checker may help you decide whether to seek medical care. Try the Ubie Symptom Checker
Your healthcare provider will typically:
The goal is to correct the metabolic imbalance:
With proper treatment, many people experience significant improvement in bone pain and muscle strength over weeks to months. Regular follow-up ensures lab values stay within target ranges and bones continue to harden.
You can take proactive steps to reduce your risk:
Osteomalacia can significantly impact quality of life if untreated. Seek prompt medical attention if you experience:
For a quick check of your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker: Ubie Symptom Checker
Always discuss any worrying or persistent symptoms with your healthcare provider. If you suspect a serious condition or life-threatening issue, call emergency services or go to your nearest emergency department immediately.
Speak to your doctor about any concerns, especially if you experience persistent symptoms or have risk factors for metabolic bone disease. Early diagnosis and treatment can help restore bone strength and protect your long-term health.
(References)
* Burtis WJ, Lang R. Chemical abnormalities. Orthop Clin North Am. 1984 Oct;15(4):653-69. PMID: 6093024.
* Francis RM, Selby PL. Osteomalacia. Baillieres Clin Endocrinol Metab. 1997 Apr;11(1):145-63. doi: 10.1016/s0950-351x(97)80569-1. PMID: 9222490.
* Robinson ME, AlQuorain H, Murshed M, Rauch F. Mineralized tissues in hypophosphatemic rickets. Pediatr Nephrol. 2020 Oct;35(10):1843-1854. doi: 10.1007/s00467-019-04290-y. Epub 2019 Aug 8. PMID: 31392510.
* Jha S, Chapman M, Roszko K. When Low Bone Mineral Density and Fractures Is Not Osteoporosis. Curr Osteoporos Rep. 2019 Oct;17(5):324-332. doi: 10.1007/s11914-019-00529-7. PMID: 31468499; PMCID: PMC6819255.
* Iatan I, Lee TC, McDonald EG. Tenofovir-induced osteomalacia with hypophosphataemia. BMJ Case Rep. 2021 May 24;14(5). doi: 10.1136/bcr-2020-240387. Epub 2021 May 24. PMID: 34031073; PMCID: PMC8149310.
* Takashi Y, Kawanami D, Fukumoto S. FGF23 and Hypophosphatemic Rickets/Osteomalacia. Curr Osteoporos Rep. 2021 Dec;19(6):669-675. doi: 10.1007/s11914-021-00709-4. Epub 2021 Nov 10. PMID: 34755323.
* Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488. PMID: 35981346; PMCID: PMC9759174.
* Courbon G, Kentrup D, Thomas JJ, Wang X, Tsai HH, Spindler J, Von Drasek J, Ndjonko LM, Martinez-Calle M, Lynch S, Hivert L, Wang X, Chang W, Feng JQ, David V, Martin A. FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice. JCI Insight. 2023 Dec 22;8(24). doi: 10.1172/jci.insight.156850. Epub 2023 Dec 22. PMID: 37943605; PMCID: PMC10807721.
* Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101851. doi: 10.1016/j.beem.2023.101851. Epub 2023 Nov 30. PMID: 38087658.
* Bandgar T, Shah N. Revisiting hypophosphatemic rickets/osteomalacia. Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101859. doi: 10.1016/j.beem.2024.101859. Epub 2024 Jan 6. PMID: 38238129.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.